Pharma company Lupin Ltd announced on Wednesday that it has received the Establishment Inspection Report (EIR) from the ...

Lupin today announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1 manufacturing facility that ...

An analyst from Master Capital Trust said that Reliance is witnessing a strong bullish setup on the monthly chart as prices ...

Nilesh Gupta, Managing Director of Lupin, emphasised that this acquisition aligns with the company’s commitment to expanding ...

Global pharma major Lupin Limited announced today the acquisition of Huminsulin® in India from Eli Lilly and Company to ...

The drug is indicated for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of HIV-1 infection in adults and adolescents. Lupin has received approval from the ...

Lupin strengthens its diabetes portfolio with the acquisition of Huminsulin products from Eli Lilly, including Insulin Human ...

Lupin Ltd. acquires Huminsulin range from Eli Lilly, strengthening its position in the Indian diabetes market.

Shares of Lupin Ltd. 1.02 per cent to Rs 2190.50 in Thursday's trade as of 11:51AM (IST). The stock hit a high price of Rs ...

The Huminsulin range is vital for managing both type 1 and type 2 diabetes, helping control blood sugar levels in adults and ...